title: Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole?
authors.affiliation: Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria, martin.hoenigl@medunigraz.at.
authors.forename: M
authors.initials: M
authors.lastname: Hoenigl
authors.forename: K
authors.initials: K
authors.lastname: Seeber
authors.forename: R
authors.initials: R
authors.lastname: Krause
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000517:prevention & control*; D001230:Aspergillus / Q000302:isolation & purification*; D019337:Hematologic Neoplasms / Q000382:microbiology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles